Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. - Wikidata - awgldk - TriplyDB

Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.

Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.

http://www.wikidata.org/entity/Q37114685

about

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders Olfactory identification deficits and increased mortality in the community Neuroimaging of Parkinson's disease: Expanding views.Association of anosmia with autonomic failure in Parkinson disease.The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases Cardiac sympathetic neuroimaging: summary of the First International Symposium.Dysautonomia in Parkinson disease MDS clinical diagnostic criteria for Parkinson's disease.Cardiac sympathetic neuroimaging in dementia with lewy bodies A cross-sectional study contrasting olfactory function in autonomic disorders A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China Olfaction in Parkinson's disease and related disorders.Survival in synucleinopathies: A prospective cohort study Combining Dopaminergic Facilitation with Robot-Assisted Upper Limb Therapy in Stroke Survivors: A Focused Review Neurocardiology: therapeutic implications for cardiovascular disease Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis.Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters.Olfaction as a biomarker in Parkinson's disease.Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.Biomarkers for the diagnosis and management of Parkinson's disease.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Spine Topographical Distribution of Skin α-Synuclein Deposits in Idiopathic Parkinson Disease.Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.Neuroimaging in the early diagnosis of neurodegenerative disease.Patients as a scientific resource: comments on receiving the Ahrens award.Potential clinical utility of multiple system atrophy biomarkers.Biomarkers for Parkinson's Disease: Recent Advancement.Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

P2860

Q26750370-C37B2663-236F-47AF-8231-FD3D07DCBE0F Q26826093-50A99E30-3F7C-4878-A261-D3C7CBC0202F Q28386484-07A79F8E-48CF-4E7B-84FB-C881EAC0B039 Q28387732-15ED25D9-60F8-4D17-9CCD-D4BD7881B1B1 Q33601323-9DCBD1F3-1123-4ED9-9F9F-EFB20E85C7AC Q34109008-C4A94527-9FB9-4112-8650-F5AA8B123685 Q34182840-7190205B-E2BC-468D-880A-7D52DA2A727E Q34235882-A287BA4A-0CE0-4855-8904-3E84B2AF0D16 Q34463831-5625A6C1-C123-46F3-90CC-39C7ADA149D7 Q34498274-114FF424-6186-4932-B558-6D200067CB51 Q34539572-431C8F9F-D9F8-4649-A759-206083D016A6 Q34555416-C7D74588-E156-4BD8-B5AD-677E31121456 Q34560077-54878E24-790B-4993-81EE-DA68EFAC2AFF Q35638948-A549571D-D0C0-44CD-A43D-807C7B4767FE Q35986671-76A0333C-0D7C-4F63-8020-D1D0C875CC7F Q36011221-9A58C1B6-0B5F-46C6-B505-3B3385A83AAE Q36092538-A040C289-BFA7-4967-93AF-1F89E130F3F6 Q36193915-C7898247-3CD4-49CB-8088-09BF1F641C7B Q36272234-A281A7B8-435C-48A5-8D95-F236E9796322 Q36900126-7DB9E4D0-9BB6-4FE1-998D-764A4B0DBC84 Q36969356-4CF42F00-6746-4090-9385-756CDE1C6DB9 Q37016518-B10CFAAA-8E9D-4279-AE65-F52636C9EFA4 Q37544921-57760E30-52D9-4CCF-90B0-17EEA6C85D57 Q37595850-9C4EE5D5-EA82-4358-ACE1-C2944CAC1703 Q37717401-54A184BB-BD66-49BC-97ED-F749FFF17489 Q37800097-85166B54-AB94-4A67-BFEB-559E18F39A9E Q37957562-6FD06A71-779F-446F-AA9A-CA67E3767A3E Q38093247-DAFFF035-F90A-4AE2-BA83-A7212C9F6F1C Q38271572-712338FC-05D5-49BC-9636-96A711A61C7E Q38752945-5108B440-B459-4C4C-BA23-C77773A06597 Q38780220-E3A405B3-BBB4-4E25-AF9F-6B2DF51C5F9A Q38840638-FC558A9C-FA17-466B-9D82-B705742F7403 Q38937893-1649D3B5-DCFA-41ED-A9EB-4E7CE08BBF03 Q39052041-925E5258-5533-420C-B013-F0208C920AFE Q41655727-7A2AD3C5-BD7F-4601-B725-9AFC25DAD856 Q42043633-74E45E4E-BBDD-4F3C-A1E1-A45598DE6DAE Q42736123-E89FD575-96E0-4300-8D45-EBCC4889111E Q47663712-9C948CA9-A0FA-40DF-8E16-AE20AE136A2C Q49942492-A4DACD11-3C38-4A5E-B556-F9AABAB1CD6D Q50566330-008DBF34-4FBD-4E88-B58E-B85BA10868D5

P2860

Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.

http://www.wikidata.org/entity/Q37114685

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarkers to detect central d ...... from multiple system atrophy.

@en

Biomarkers to detect central d ...... from multiple system atrophy.

@nl

type

label

Biomarkers to detect central d ...... from multiple system atrophy.

@en

Biomarkers to detect central d ...... from multiple system atrophy.

@nl

prefLabel

Biomarkers to detect central d ...... from multiple system atrophy.

@en

Biomarkers to detect central d ...... from multiple system atrophy.

@nl

P1433

Q37114685-0FF9485E-6E88-48F0-B0A0-9653899E07E1

P1476

Q37114685-9A581516-D815-4C78-BEF4-9E36DC678E40

P2093

Q37114685-07C0F30D-8C25-4843-B248-1059C1BE956C

Q37114685-31DA98B5-BA3D-4686-BFBD-F6C1601C39E7

Q37114685-3C407866-27A0-4DCD-A4DE-5D0B02848EE0

Q37114685-3F5A4EBC-5431-45CD-816B-5593CBC85572

Q37114685-AF2BF749-A08E-4657-996D-BE7C519FE772

Q37114685-C33DBC2E-B28D-4622-9BB7-1ACFF2AF138F

Q37114685-C5B61E13-B800-4457-B0BB-19989156621B

Q37114685-CF109A2F-CDBC-42A3-BA0B-6ED90C83A0FC

Q37114685-F262586E-AE1E-415E-982E-6BD5C9048571

P2860

Q37114685-0C5CD8F1-0153-4873-A13D-8FEDF7A2B2AB

Q37114685-12685EDC-E0C6-4A46-8D89-8249516C0ECB

Q37114685-1F05FE4B-8D2D-40B2-A0FE-45333E9A2701

Q37114685-4B68367D-CE71-4985-BACC-24F6BB28C1D3

Q37114685-50B9754A-A1AD-4DE0-9460-B4943D9EF6ED

Q37114685-536FD1EC-9700-4893-AF30-E4D3BD6A8773

Q37114685-5E0F6755-86A7-407D-BF4D-82FE495CE306

Q37114685-60492FC4-1A81-49C8-B7BB-58A676CAF24E

Q37114685-661ED1B7-039A-4FC5-B4AA-28B7886DA0FF

Q37114685-667800A7-57E8-4D8D-8FE9-A1D40DEB701A

P304

Q37114685-8F349657-DD67-4EA8-8441-57B761DA5C0F

P31

Q37114685-3AE74C7B-888C-4CB8-A9C0-28263C3D6E24

P356

Q37114685-61AD846F-0AFB-4EEE-B794-582966C7594C

P433

Q37114685-3DD2A12F-9AC8-41DC-91F9-7A59FB6E5CBC

P478

Q37114685-5C2688C9-B45A-41B0-BC03-C0A92A353240

P577

Q37114685-CB2636B7-E650-40EF-87D3-F7CC321245AA

P5875

Q37114685-CA726875-0BAB-4043-84B1-BE8EFFD2ECF3

P698

Q37114685-25C2D925-3142-49D2-B440-9C1F148FFE78

P921

Q37114685-A0676C97-3C7A-4D0E-B126-2CB374A67AC1

Q37114685-BC5D24F2-FD47-4052-9DD6-9829B740976E

Q37114685-ef7b1ef5-ba87-4e6a-bda1-11cdef3938c3

P932

Q37114685-16B16485-4DE6-4B82-AFF1-B36E76509F6C

P356

J.PARKRELDIS.2008.01.010

P1433

Parkinsonism and Related Disorders

P1476

Biomarkers to detect central d ...... from multiple system atrophy.

@en

P2093

Basil A Eldadah

http://www.w3.org/2001/XMLSchema#string

Courtney Holmes

http://www.w3.org/2001/XMLSchema#string

David S Goldstein

http://www.w3.org/2001/XMLSchema#string

Jeffrey Moak

http://www.w3.org/2001/XMLSchema#string

Oladi Bentho

http://www.w3.org/2001/XMLSchema#string

Richard Imrich

http://www.w3.org/2001/XMLSchema#string

Shielah Conant

http://www.w3.org/2001/XMLSchema#string

Takuya Sato

http://www.w3.org/2001/XMLSchema#string

Yehonatan Sharabi

http://www.w3.org/2001/XMLSchema#string

P2860

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.

Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.

Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure

Clinicopathological study of 35 cases of multiple system atrophy.

Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.

The role of radiotracer imaging in Parkinson disease.

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy.

CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.

Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy.

D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain.

P304

600-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PARKRELDIS.2008.01.010

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5526100

http://www.w3.org/2001/XMLSchema#string

P698

18325818

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2650101

http://www.w3.org/2001/XMLSchema#string